Clover Health CLOV
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 100th percentile, 5-year average -15.8x
#2973 of 2993 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 97th percentile, 5-year average 3.4x
#4688 of 5330 stocks by PB (1 = cheapest)
Above its usual level · 74th percentile, 5-year average 0.7x
#1642 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 6.79 | – | 3.41 | 97% (pricier than usual) | #4688 of 5330 (1 = cheapest) |
| PE | 496.00 | 59.10 | -15.77 | 100% (pricier than usual) | #2973 of 2993 (1 = cheapest) |
| PS | 0.97 | 0.76 | 0.74 | 74% (pricier than usual) | #1642 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on CLOV.
Sign in to join the discussion.